The Cigna Group Reports Strong Second Quarter 2025 Results
The Cigna Group, a global health company, has released its financial results for the second quarter of 2025, showcasing robust performance across its diverse portfolio. The company reported significant growth in revenues and reaffirmed its adjusted EPS outlook for the year.
Financial Highlights
For the second quarter of 2025, The Cigna Group reported total revenues of $67.2 billion, marking an 11% increase compared to the same period in 2024. Shareholders' net income stood at $1.5 billion, or $5.71 per share, consistent with the previous year's $1.5 billion, or $5.45 per share. Adjusted income from operations was $1.9 billion, or $7.20 per share, up from $1.9 billion, or $6.72 per share, in the second quarter of 2024.
Business and Operational Highlights
The company's growth was primarily driven by Evernorth Health Services, which saw strong specialty pharmacy growth and the expansion of existing client relationships. The SG&A expense ratio improved to 5.1% from 6.1% in the previous year, reflecting a favorable business mix and strong revenue growth.
Strategic Initiatives and Corporate Developments
The Cigna Group reaffirmed its 2025 outlook for adjusted income from operations of at least $29.60 per share. The company also highlighted the impact of the HCSC transaction, which influenced the total number of medical customers and adjusted revenues for Cigna Healthcare.
Management's Perspective
David M. Cordani, Chairman and CEO of The Cigna Group, emphasized the company's commitment to listening, adapting, and innovating to meet the evolving needs of patients, customers, and clients. He noted that the strong performance in the second quarter reflects disciplined execution and the strength of the business mix.
Future Outlook
The Cigna Group's outlook for the full year 2025 includes consolidated adjusted income from operations of at least $29.60 per share. This projection accounts for expected future share repurchases and anticipated dividends for the year.
SEC Filing: Cigna Group [ CI ] - 8-K - Jul. 31, 2025